Abstract
A prospective randomized trial was conducted to determine the efficacy and safety of ceftazidime sodium carbonate versus a new arginine formulation of ceftazidime as empirical monotherapy in 100 febrile neutropenic patients. The clinical cure rate for ceftazidime sodium carbonate was 91% and for ceftazidime arginine 83%. Forty-two infections could be confirmed bacteriologically. Bacteriological cure rates were 87% and 81% respectively. Only one fatal infection-related outcome occurred during the first three days of therapy (ceftazidime arginine,Corynebacterium parvum). No failures were recorded in bacteriologically proven gram-negative infections. Ceftazidime was confirmed to be safe and effective as empirical monotherapy in febrile neutropenic patients. The arginine formulation is as effective and safe as the sodium carbonate formulation, but easier to handle.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bodey, G.P., Rodriguez, V., Valdivieso, M., Feld, R. Amikacin for treatment of infections in patients with malignant diseases. Journal of Infectious Diseases 1976, 134: S421-S427.
Fainstein, V., Bodey, G.P., Bolivar, R., Elting, L., McCredie, K.B., Keating, M.J. Moxalactam plus ticarcillin or tobramycin for treatment of febrile episodes in neutropenic cancer patients. Archives of Internal Medicine 1984, 144: 1766–1770.
Keating, M.J., Bodey, G.P., Valdivieso, M., Rodriguez, V. A randomized comparative trial of three aminoglycosides: comparison of continous infusions of gentamicin, amikacin and sisomycin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies. Medicine 1979, 58: 159–170.
Winston, D.J., Ho, W.G., Young, L.S., Hewit, W.L., Gale, R.P. Piperacillin plus amikacin therapy versus carbenicillin plus amikacin therapy in febrile granulocytopenic patients. Archives of Internal Medicine 1982, 142: 1663–1667.
Norris, S.M., Guenthner, S.H., Wenzel, R.P. Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures. Journal of Antimicrobial Chemotherapy 1985, 16: 183–188.
Rolinson, N. Beta-lactam antibiotics. Journal of Antimicrobial Chemotherapy 1986, 17: 5–36.
Donnelly, J.P., Marcus, R.E., Goldman, J.M., Cohen, J., Worsley, A.M., Catovsky, D., Darrell, J.H., Want, S.V., Galton, D.A.G. Ceftazidime as first line therapy for fever in acute leukaemia. Journal of Infection 1985, 11: 205–215.
Fainstein, V., Bodey, G.P., Elting, L., Bolivar, R., Keating, M.J., McCredle, K.B., Valdivieso, M. A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients. Journal of Antimicrobial Chemotherapy 1983, 12, Supplement A: 101–110.
Pizzo, P.A., Thaler, M., Hathorn, J., Skelton, J., McKnight, J., Rubin, M., Browne, M., Longo, D., Cotton, D., Gress, J., Marshall, D. New beta-lactam antibiotics in granulocytopenic patients, new options and new questions. American Journal of Medicine 1985, 79, Supplement 2A: 75–82.
Pizzo, P.A., Hathorn, J.W., Hiemenz, J., Browne, M., Commers, J., Cotton, D., Gress, J., Longo, D., Marshall, D., McKnight, J., Rubin, M., Skelton, J., Thaler, M., Wesley, R. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. New England Journal of Medicine 1986, 315: 552–558.
De Pauw, B.E., Kauw, F., Muytjens, H., Williams, K.J., Bothof, T. Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patients. Journal of Antimicrobial Chemotherapy 1983, 12, Supplement A: 93–99.
De Pauw, B.E., Williams, K., De Neef, J., Bothof, T., De Witte, T., Holdrinet, R., Haanen, C. A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients. Antimicrobial Agents and Chemotherapy 1985, 28: 824–828.
Verhagen, C., De Pauw, B.E., De Witte, T., Janssen, J., Williams, K., De Mulder, P., Bothof, T. Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in the empiric treatment of febrile episodes in severely neutropenic patients. Antimicrobial Agents and Chemotherapy 1987, 31: 191–196.
Meyers, B. R. Comparative toxicities of the third-generation cephalosporins. American Journal of Medicine 1985, 79, Supplement 2A: 96–103.
Verhagen, C., De Pauw, B.E., De Witte, T., Holdrinet, R.S.G., Janssen, J.Th.P., Williams, K.J. Ceftazidime does not enhance cyclosporin-A nephrotoxicity in febrile bone marrow transplantation patients. Blut 1986, 52: 333–339.
Wade, J.C., Schimpff, S.C., Newman, K.A., Wiernik, P.H. Staphylococcus epidermidis: An increasing cause of infection in patients with granulocytopenia. Annals of Internal Medicine 1982, 97: 503–508.
Bodey, G.P., Bolivar, R., Fainstein, V. Infectious complications in leukemic patients. Seminars in Hematology 1982, 19: 193–226.
Klastersky, J., Glauser, M.P., Schimpff, S.C., Zinner, S.H., Gaya, H., EORTC Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infections in febrile granulocytopenic patients. Antimicrobial Agents and Chemotherapy 1986, 29: 263–270.
Bodey, G.P., Buckley, M., Sathi, Y.S. Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Annals of Internal Medicine 1966, 64: 328–339.
Neu, H.C. Relation of structural properties of betalactam antibiotics to antibacterial activity. American Journal of Medicine 1985, 79, Supplement 2A: 2–13.
Sickles, E.A., Greene, W.H., Wiernik, P.H. Clinical presentation of infection in granulocytopenic patients. Archives of Internal Medicine 1975, 135: 715–719.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Verhagen, C., De Pauw, B.E., Williams, K.J. et al. Ceftazidime sodium carbonate versus ceftazidime arginine as empirical monotherapy in febrile neutropenic patients. Eur. J. Clin. Microbiol. Infect. Dis. 7, 178–182 (1988). https://doi.org/10.1007/BF01963075
Issue Date:
DOI: https://doi.org/10.1007/BF01963075